EPO Grants Patent for Antigen-Presenting Cell-Mimetic Scaffolds

The European Patent Office (EPO) has granted patent EP3484448B1 for antigen-presenting cell-mimetic scaffolds and methods for their creation and use. The patent was published on March 18, 2026, and lists Alexander Sing Cheung and David J. Mooney as inventors.

EPO Patent Grant EP3386554B1 for Bacterial Cellulose Membranes

The European Patent Office has granted patent EP3386554B1 for methods of producing biosynthetic bacterial cellulose membranes. The patent lists inventors from Schwarz, Chaid, Kumar, Vijay, and Raghavan, Madhavan, and covers various International Patent Classifications related to medical materials and biotechnology.

EPO Patent EP3383999B1: Stable dry compositions with little sugars

The European Patent Office has granted patent EP3383999B1 for stable dry compositions with little or no sugars. The patent, effective March 18, 2026, covers specific formulations and their applications, impacting entities involved in biotechnology and pharmaceutical development.

EPO Patent Grant EP3334765B1: CARs Based on Single-Domain Antibodies

The European Patent Office has granted patent EP3334765B1 for chimeric antigen receptors (CARs) based on single-domain antibodies and their methods of use. This patent, effective March 18, 2026, covers innovations in the field of biotechnology and therapeutic applications.

EPO Patent EP3394277B1: Improved Granular Starch Conversion Enzymes

The European Patent Office has granted patent EP3394277B1 for improved granular starch conversion enzymes and methods. This patent, effective March 18, 2026, covers specific biotechnological innovations in enzyme technology.

EPO Patent Grant EP3366126B1: Transgenic Mice for Antibody Production

The European Patent Office has granted patent EP3366126B1 for transgenic mice engineered to express human lambda immunoglobulin light chain variable domains. This patent, effective March 18, 2026, relates to advancements in antibody production and biotechnology.

EPO Patent EP3262065B1: Dystroglycanopathy Treatment Methods

The European Patent Office has granted patent EP3262065B1 for methods and compositions for treating dystroglycanopathy disorders. This patent, effective March 18, 2026, covers specific treatment approaches and related compositions.

EPO Patent Grant EP3121280B1 for Antisense Compositions

The European Patent Office (EPO) has granted patent EP3121280B1 for antisense compositions and methods of making and using them. The patent was granted on March 18, 2026, and covers inventions by inventors Sergio Baroni, Salvatore Bellinvia, and Francesca Viti.

EPO Patent Granted for Human Tissue Derived Compositions

The European Patent Office (EPO) has granted patent EP3474869B1 for human tissue derived compositions and their uses. The patent was published on March 18, 2026, and covers various applications in biotechnology and medicine.

Immunotherapy Patent Grant EP3465203B1

The European Patent Office (EPO) has published patent grant EP3465203B1 concerning methods of immunotherapy. The patent, listing Rajiv Khanna and Corey Smith as inventors, was published on March 18, 2026. This grant is part of the EPO's ongoing dissemination of intellectual property information.